Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial

A Meisel, S von Felten, D R Vogt, H Liewen, Ronald de Wit, J De Bono, O Sartor, F Stenner-Liewen

Research output: Contribution to journalArticleAcademicpeer-review

53 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)93-100
Number of pages8
JournalEuropean Journal of Cancer
Volume56
DOIs
Publication statusPublished - 2016

Cite this